TAKEDA PHARMACEUTICAL CO LTD
CIK 1395064 · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PHAT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TOKYO, M0 103-8668
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OVID | 10%+ Owner | 8,781,996 | $2.54 | $22.31M | $0 | 2 | 2025-12-09 |
| PHAT | 10%+ Owner | 3,755,583 | $5.74 | $21.56M | -$58.48M | 22 | 2024-01-25 |
| HilleVax, Inc. (HLVX) Delisted | 10%+ Owner | 6,724,000 | $2.09 | $14.05M | $0 | 1 | 2022-12-01 |
| Calithera Biosciences, Inc. (CALA) Delisted | 10%+ Owner | — | $0.00 | — | $0 | 1 | 2022-07-06 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | 10%+ Owner | 6,230,462 | $21.53 | $134.14M | -$29.97M | 2 | 2021-12-09 |
| XLO | 10%+ Owner | 105,366 | $8.03 | $846.1K | $0 | 1 | 2021-10-26 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | 10%+ Owner | 1,615,427 | $4.06 | $6.56M | $0 | 1 | 2021-10-15 |
| Translate Bio, Inc. (TBIO) Delisted | 10%+ Owner | 387,248 | $0.00 | $39 | -$8.47M | 1 | 2020-06-03 |
Recent Filings · Page 2 of 4
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-15 | Theseus Pharmaceuticals, Inc. (THRX) Delisted | Conv (C) | +3,230,854 | $0 | EDGAR |
| 2021-07-09 | PHAT | Sell (S) | −2,609 | -$91.4K | EDGAR |
| 2021-07-06 | PHAT | Sell (S) | −8,326 | -$292.7K | EDGAR |
| 2021-06-29 | PHAT | Sell (S) | −24,501 | -$869.4K | EDGAR |
| 2021-06-25 | PHAT | Sell (S) | −11,048 | -$388.2K | EDGAR |
| 2021-06-23 | PHAT | Sell (S) | −9,394 | -$331.7K | EDGAR |
| 2021-06-21 | PHAT | Sell (S) | −8,703 | -$305.6K | EDGAR |
| 2021-06-16 | PHAT | Sell (S) | −2,826 | -$99.1K | EDGAR |
| 2021-06-11 | PHAT | Sell (S) | −3,293 | -$115.9K | EDGAR |
| 2021-06-09 | PHAT | Sell (S) | −2,364 | -$82.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.